Vidaza and cerebrovascular accident Patient Reports February 12, 2012

Vidaza Side Effects Report #5643881-6
Vidaza side effect was reported by a Health Professional from UNITED STATES on Feb 14, 2008. Male patient, 65 years of age, weighting 176.4 lb, was diagnosed with myeloproliferative disorder and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , bone marrow disorder, cerebrovascular accident, musculoskeletal pain, necrosis, rash erythematous, respiratory disorder, splenic infarction. Vidaza dosage: 75 MG/M2,DAILY X 5 DAYS , INTRAVENOUS. During the same period patient was treated with PROCHLORPERAZINE MALEATE, DOCUSATE, SENNA, FIBERCON, BENADRYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4867941-2
Vidaza side effect was reported by a Physician from SWITZERLAND on Dec 16, 2005. Male patient, 81 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, atrial fibrillation , cerebrovascular accident, condition aggravated, confusional state, embolism, fall , performance status decreased, renal impairment. Vidaza dosage: 120 MG (120 MG, ONCE DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, TORASEMIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #6054315-4
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 21, 2009. Male patient, 80 years of age, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome, pain , depression , cough and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, cerebrovascular accident, clostridium difficile colitis, nausea , renal failure acute, tachycardia, thrombocytopenia. Vidaza dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ALBUTEROL S, BUPROPION, CODEINE SUL, FORMOTEROL FUMARATE, IPRATROPIUM BROMIDE, LISINOPRIL, MEGESTROL ACETATE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #6054323-3
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 21, 2009. Male patient, 80 years of age, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome, pain , depression , cough and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, cerebrovascular accident, clostridium difficile colitis, nausea , renal failure acute, tachycardia, thrombocytopenia. Vidaza dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ALBUTEROL S, BUPROPION, CODEINE SUL, FORMOTEROL FUMARATE, IPRATROPIUM BROMIDE, LISINOPRIL, MEGESTROL ACETATE. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5060546-2
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebrovascular accident, haemorrhage, pneumonia , sepsis . Vidaza dosage: unknown. During the same period patient was treated with LIPITOR, ATIVAN. Patient was hospitalized. Patient died on 02/16/2006.

Vidaza Side Effects Report #4638334-8
Vidaza side effect was reported by a Physician from on Apr 04, 2005. Female patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cerebrovascular accident, condition aggravated, haemoglobin decreased, neutropenia, platelet count decreased, platelet count increased, pneumonia . Vidaza dosage: 150 MG ( 7 DAYS/MONTH), SUBCUTANEOUS. During the same period patient was treated with OFLOCET, AMPICILLIN. Patient was hospitalized. Patient died on 04/01/2005.